• 1. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidine-2-ones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidones Pyrrolidine-2-ones

Introduction to (5S)-5-(methylamino)methylpyrrolidin-2-one (CAS No. 1909294-11-6)

(5S)-5-(methylamino)methylpyrrolidin-2-one is a significant compound in the field of pharmaceutical chemistry, renowned for its versatile applications in drug development and molecular research. This compound, identified by the chemical abstracts service number CAS No. 1909294-11-6, has garnered considerable attention due to its unique structural properties and potential therapeutic benefits. The detailed exploration of this molecule not only highlights its chemical significance but also underscores its role in advancing modern medicinal chemistry.

The molecular structure of (5S)-5-(methylamino)methylpyrrolidin-2-one consists of a pyrrolidinone core substituted with a methylamino group at the 5-position and a chiral center at the 5-position, which contributes to its stereochemical complexity. This configuration makes it a valuable scaffold for designing enantiomerically pure drugs, which are often crucial for achieving optimal pharmacological effects while minimizing side reactions. The presence of the pyrrolidinone ring enhances the compound's solubility and bioavailability, making it an attractive candidate for further pharmacokinetic studies.

In recent years, there has been a surge in research focusing on the development of novel therapeutic agents derived from heterocyclic compounds. Among these, (5S)-5-(methylamino)methylpyrrolidin-2-one has emerged as a promising intermediate in the synthesis of various bioactive molecules. Its chiral nature allows for the creation of enantiomerically enriched libraries, which are essential for high-throughput screening and lead optimization in drug discovery programs. The compound's ability to serve as a building block for more complex structures has positioned it as a cornerstone in medicinal chemistry innovation.

One of the most compelling aspects of (5S)-5-(methylamino)methylpyrrolidin-2-one is its potential application in treating neurological disorders. Preliminary studies have suggested that derivatives of this compound may exhibit neuroprotective and anti-inflammatory properties, making them viable candidates for therapies targeting conditions such as Alzheimer's disease and Parkinson's disease. The chiral center at the 5-position plays a pivotal role in modulating these pharmacological effects, ensuring that only the active enantiomer is retained during synthesis.

The synthesis of (5S)-5-(methylamino)methylpyrrolidin-2-one involves multi-step organic reactions that require precise control over reaction conditions to achieve high enantiomeric purity. Advanced synthetic methodologies, including asymmetric catalysis and chiral resolution techniques, are employed to isolate the desired stereoisomer. These processes not only highlight the compound's synthetic challenge but also underscore the importance of cutting-edge chemical techniques in modern drug development.

Recent advancements in computational chemistry have further enhanced our understanding of (5S)-5-(methylamino)methylpyrrolidin-2-one. Molecular modeling studies have revealed insights into its binding interactions with biological targets, providing valuable data for rational drug design. By leveraging computational tools, researchers can predict how different derivatives of this compound will interact with enzymes and receptors, thereby accelerating the discovery of novel therapeutic agents.

The pharmaceutical industry has taken note of the potential of (5S)-5-(methylamino)methylpyrrolidin-2-one and has initiated several preclinical studies to evaluate its efficacy and safety profile. These studies aim to establish a strong foundation for future clinical trials, where the compound could be tested in human subjects suffering from various diseases. The outcomes of these trials will not only validate the therapeutic potential of this molecule but also open doors for new treatment strategies across multiple therapeutic areas.

In conclusion, (5S)-5-(methylamino)methylpyrrolidin-2-one (CAS No. 1909294-11-6) represents a significant advancement in pharmaceutical chemistry. Its unique structural features, coupled with its potential applications in drug development, make it a compound of great interest to researchers and industry professionals alike. As our understanding of its properties continues to evolve, so too will its role in shaping the future of medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)